NASDAQ: RKDA
Arcadia Biosciences, Inc.
Basic Materials · Agricultural Inputs
Market Cap
$1.20M
52w High
$6.71
52w Low
$0.77
P/E
-0.11
Volume
71.17K
Outstanding Shares
1.55M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 84.13% over the last year. Revenue declined 9.53% over the trailing twelve months. Operating margin moved from -62.35% to -200.78%. Free cash flow grew 46.93% over the trailing twelve months.
What the market seems to be pricing
The market is reacting to weaker business momentum more than just compressing the valuation multiple. Even if the shares already screen cheap on P/S, investors are still discounting lower future earnings power.
What would invalidate this read
Operating margin stands at -200.78%. Revenue declined 9.53% — this read reverses if that trend stabilizes. If margins and cash flow stabilize while the stock stays depressed, the gap shifts from fundamental damage toward pure multiple compression.
Company profile
Arcadia Biosciences, Inc. is a U.S.-based company that provides plant-derived health and well-being products.
Valuation
Stock splits
Every 40 shares became 1
Every 20 shares became 1
Profitability & growth
Analyst consensus
4
Buy
1
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 19, 2026
Q3 FY26 · EPS est -$0.56 · Revenue est $1.9M
View